Big world - global opportunity25 Oct 2021 11:38
Fair play to highlight potential risks (of masking underlying health conditions), however, there is a massive market for OTC ED treatments, different geographies will have different regulatory / risk approaches. FUM, with or without big pharma, will navigate a commercial course that gives long term investors a very healthy return.
All IMHO and my own musings
GLALTH